AnalystsAndres Y. Maldonado
Andres Y. Maldonado's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 23%
#1188 out of 5156 analysts
Average Return
+14.41%
Win Rate
52%12 out of 23
Risk vs Reward
Poor
Good

Andres Y. Maldonado's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Terns Pharmaceuticals IncTERN
+140.85%$17.43$41.98
2025-11-04 -
2025-12-17
Buy
Monopar TherapeuticsMNPR
+111.36%$32.03$67.70
2025-08-26 -
2025-12-17
Buy
Syndax Pharmaceuticals IncSNDX
+55.38%$13.11$20.37
2025-10-27 -
2025-12-17
Buy
Keros Therapeutics IncKROS
+51.71%$13.73$20.83
2025-08-08 -
2025-12-17
Buy
Engene Holdings IncENGN
+43.54%$5.43$7.79
2025-09-08 -
2025-12-17
Buy

Andres Y. Maldonado Analyst Color

Get additional color on Andres Y. Maldonado's coverage of popular stocks

Andres Y. Maldonado's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Terns Pharmaceuticals IncTERN
2Buy$60.00+42.93%Maintains
10 days ago
Protara Therapeutics IncTARA
2Buy$23.00+329.91%Reiterates
15 days ago
Day One Biopharmaceuticals IncDAWN
1Buy$25.00+185.39%Reiterates
24 days ago
Tscan Therapeutics IncTCRX
1Buy$7.00+653.50%Maintains
a month ago
Syndax Pharmaceuticals IncSNDX
2Buy$40.00+96.37%Reiterates
2 months ago
Corbus Pharmaceuticals Holdings IncCRBP
2Buy$40.00+390.80%Reiterates
2 months ago
Merus NvMRUS
1Hold$97.00+0.11%Downgrades
3 months ago
Candel Therapeutics IncCADL
1Buy$23.00+318.18%Reiterates
3 months ago
Monopar TherapeuticsMNPR
2Buy$105.00+55.10%Maintains
3 months ago
Scholar Rock Holding CorpSRRK
1Buy$44.00-0.02%Maintains
3 months ago
Cg Oncology IncCGON
3Buy$75.00+100.70%Reiterates
3 months ago
Engene Holdings IncENGN
2Buy$25.00+220.76%Reiterates
3 months ago
Immunitybio IncIBRX
1Buy$8.00+279.15%Reiterates
3 months ago
Novabridge BiosciencesNBP
1Buy$7.00+69.49%Reiterates
4 months ago
Aura Biosciences IncAURA
1Buy$22.00+276.07%Reiterates
4 months ago
Keros Therapeutics IncKROS
1Buy$20.00-3.98%Maintains
4 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.